Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of the enzymes need
for cell growth. Drugs used in chemotherapy, such as docetaxel, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving celecoxib together with docetaxel or pemetrexed may kill more tumor cells.
PURPOSE: This phase II trial is studying how well celecoxib given together with docetaxel or
pemetrexed works in treating patients with advanced or recurrent non-small cell lung cancer.